- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00868400
Clinical Value of Preoperative Oral Carbohydrate Loading in Colorectal Surgery
March 9, 2015 updated by: Mehmet Fatih Can, Gulhane School of Medicine
Multi-centre Double-blind Randomized Trial of the Clinical Value of Preoperative Oral Carbohydrate Loading in Colorectal Surgery.
The aim of this study is to provide conclusive clinical evidence as to whether or not the preoperative administration of oral carbohydrate-rich solutions is effective on the outcomes of patients undergoing colorectal surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Preoperative oral carbohydrate loading is an issue that has been investigated extensively in terms of its fundamental and biochemically apparent effects and potential benefits.
Most commonly, proponents of the application advocate that it may be beneficial for improving patient outcomes and for decreasing complication rate by attenuating postoperative insulin resistance.
To date, however, no study with a sufficient sample size has been able to demonstrate that it has a marked value in clinical practice.
Almost all of the clinical benefits ascribed to the application have been based on subjective well-being, which can also be provided with non specific simple beverages.
A study conducted to show whether or not the application has direct influence on patient outcome, therefore, could significantly contribute insights on this topic.
The present study was planned to consist of three study arms, namely: 1.Study group, which will be given high-carbohydrate beverage (Nutricia preOp®, Numico, Zoetermeer, The Netherlands) 2. Placebo group, which will be given flavored water, and 3. Control group (surgery after overnight fast).
The revised power analysis shows that an accrual of 74 patients in each group would allow detecting a 15% difference in the rate of complications with 80% power at the 5% level of significance (two tailed).
We hope we will have recruited at least 220 subjects at the end of a two-year course.
Once the data recording is complete, this study will be the largest one ever conducted to investigate this topic.
Study Type
Interventional
Enrollment (Actual)
215
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06018
- Gulhane School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 80 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients undergoing colorectal surgery for malignant or benign diseases
Exclusion Criteria:
- diabetes
- disorders that prolongs gastric emptying
- existence of an increased risk for aspiration of gastric content
- anal surgery (haemorrhoidectomy, fistulotomy...etc)
- emergency operations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: 2
Placebo
|
will be given in doses equal to those of high-carbohydrate beverage
|
No Intervention: 3
Control
|
|
Experimental: 1
High-carbohydrate
|
800 ml before the day of surgery, and additional 400 ml two hours prior to surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Overall 30-day complication rate
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Patient discomfort
Time Frame: 2 years
|
2 years
|
need for insulin infusion
Time Frame: 2 years
|
2 years
|
Length of intensive care unit and hospital stay
Time Frame: 2 years
|
2 years
|
Patient recovery
Time Frame: 2 years
|
2 years
|
Overall 30-day mortality rate
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Mehmet F Can, Assist Prof, Gulhane School of Medicine, Department of Surgery
- Principal Investigator: Avdyl Krasniqi, MD, PhD, University Clinical Centre of Kosova, Department of Surgery
- Principal Investigator: Costas Vagianos, Assoc Prof, Agios Panteleimon Regional Hospital, Deparment of Surgery
- Principal Investigator: Gokhan Yagci, Assoc Prof, Gulhane School of Medicine, Department of Surgery
- Principal Investigator: Gyorgy Lazar, Prof, University of Szeged, Department of Surgery
- Principal Investigator: Wim P Ceelen, MD, PhD, Prof, Ghent University Hospital, Department of Surgery
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
March 24, 2009
First Submitted That Met QC Criteria
March 24, 2009
First Posted (Estimate)
March 25, 2009
Study Record Updates
Last Update Posted (Estimate)
March 10, 2015
Last Update Submitted That Met QC Criteria
March 9, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- PRECALICS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Disorders
-
Institut Paoli-CalmettesNot yet recruitingColorectal Disorders
-
Leonardo Bustamante-LopezRodrigo Ambar PintoUnknownColorectal DisordersBrazil
-
Katherine DeansSociety of University SurgeonsCompleted
-
Mayo ClinicCompleted
-
Joanne TurnerRecruitingColorectal DisordersUnited Kingdom
-
Mount Sinai Hospital, CanadaRecruiting
-
Hospital Universitario La FeUnknown
-
Barts & The London NHS TrustCompletedColorectal DisordersUnited Kingdom
-
Sunnybrook Health Sciences CentreCancer Care OntarioCompletedColorectal Disorders
-
University Hospital, GenevaUnknown
Clinical Trials on commercially available high-carbohydrate beverage
-
USDA Beltsville Human Nutrition Research CenterUnited States Army Research Institute of Environmental MedicineCompletedHealthy VolunteersUnited States
-
University of ValenciaCompletedBone Resorption | Dental ImplantSpain
-
Old Dominion UniversityRecruitingAnomalies GastrointestinalUnited States
-
Old Dominion UniversityCompletedImpaired ThermoregulationUnited States
-
MedtronicNeuroRecruitingPain, Chronic | Pain, IntractableUnited States
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Colorado State UniversityInstitute of Cannabis Research (ICR)--Colorado State University, PuebloRecruitingAlcohol Use Disorder | Cannabis UseUnited States
-
Kangbuk Samsung HospitalCompleted
-
Massachusetts General HospitalHarvard School of Public Health (HSPH)Completed
-
University of FloridaHeermann Anesthesia FoundationCompleted